The analysis of the impact of alfa-defensin on bacterial translocation in chronic liver disease

The analysis of the impact of alfa-defensin on bacterial translocation in chronic liver disease - The analysis of the impact of alfa-defensin on bacterial translocation in chronic liver disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019043

Enrollment

200

Registered

2015-09-24

Start date

2015-09-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The age of 20 years or older at the time of obtaining informed consent 2. obtained written informed consent

Exclusion criteria

Exclusion criteria: 1. Patient severe liver dysfunction 2. Other patients by whom principal investigator has determined to be inappropriate as a subject

Design outcomes

Primary

Measure	Time frame
Quantification of alfa-defensin using by ELISA	—

Countries

Japan

Contacts

Public ContactKenichi Morikawa

Hokkaido University Hospital Gastroenterology and Hepatology

kenichi.morikawa@med.hokudai.ac.jp011-716-1161

Outcome results